CWR:Ceres Power goes from bad to worse, losing another 8% and suggesting they won't stay in the FTSE 250 for very long.
TRX:Tissue Regenix dropped 8% presumably because nothing seems to be forthcoming on whether they are selling the company.
FXPO:Ferrexpo lost 5% as they continue to yo-yo.
III:3i Group just keeps delivering, with another 5% growth this week taking them to 121% up.
SAE:Simec Atlantis Energy rose 5% for no clear reason.
GAW:Games Workshop rose a whopping 15% to go 46% up.
SBTX:SkinBioTherapeutics reversed last week's decline and went up 19%.
Share of the Week is PAF:Pan African Resources which rebounded from a 10% loss last week to go up by 21% and my cheapest holding is now £122% up.
Here's the ISA and shares portfolio after week 17 of year 10.
| Weekly Change | |||
| Cash | £3.15 | +£0 | |
| Portfolio cost | £111,553.84 | +£0 | |
|
Portfolio sell value (bid price-commission) |
£43,268.73 | (-61.2%) | -£884.24 |
| Potential profits | £0 | +£0 | |
| Yr 10 Dividends | £53.50 | +£0 | |
| Yr 10 Interest | £0.40 | +£0 | |
| Yr 10 Profit from sales | £243.66 | +£0 | |
| Yr 10 proj avg monthly profit | £68.50 | (1.0%) | -£4.28 |
| Total Dividends | £12,275.99 | +£0 | |
| Total Interest | £7.20 | +£0 | |
| Total Profit from sales | £18,121.50 | +£0 | |
| Average monthly cash profit | £267.22 | (3.9%) | -£0.55 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 36% | +0% |
Quite a big drop in value and no gold to off-set.
Slowly wiping out the gains from a few weeks ago,
Determined not to cross the trend line
The SIPP looks like this after week 469 overall and week 1 of year 10.
| Weekly Change | ||||
| Cash | £112.35 | +£0 | ||
| Portfolio cost | £119,221.31 | +£0 | ||
| Portfolio sell value (bid price - commission) | £61,461.15 | (-48.4%) | +£360.66 | |
| Potential profits | £6,316.33 | +£1,441.99 | ||
| Yr 9 Dividends | £0 | +£0 | ||
| Yr 9 Interest | £0 | +£0 | ||
| Yr 9 Profit from sales | £0 | +£0 | ||
| Yr 9 proj avg monthly profit | £0 | (0.0%) | +£0 | |
| Total Dividends | £16,116.65 | +£0 | ||
| Total Interest | £12.90 | +£0 | ||
| Total Profit from sales | £17,007.94 | +£0 | ||
| Average monthly cash profit | £293.41 | (4.5%) | -£0.63 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 40% | +0% |
Much better performance here, with potential profits up by £1,441 and portfolio value also up.
Boring
Determined to stay under the trend line
The trading account looks like this after week 435 overall and week 19 of year 9.
| Weekly Change | |||
| Cash | £63.39 | +£0 | |
| Portfolio cost | £2,073.87 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,265.29 | (-39.0%) | +£34.13 |
| Potential profits | £0 | +£0 | |
| Year 9 Dividends | £0 | +£0 | |
| Year 9 Interest | £0 | +£0 | |
| Year 9 Profit | £0 | +£0 | |
| Yr 8 proj avg monthly profit | £0 | (+0%) | +£0 |
| Dividends | £85.46 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£602.54 | +£0 | |
| Average monthly cash profit | -£5.15 | (-3.0%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Pretty good thanks to SBTX:SkinBioTherapeutics.
Back to heading upwards
Touching the trend line!
No comments:
Post a Comment